2m 2m 2m 2m 2m 2m 2m
GENMAB SP ADR (GMAB)
NASDAQ
$25.94+$0.33 (+1.29%)
Price as of Jun 23, 2026 4:37 PM EDT- $15.7BMarket Cap
- 23.84%1-Year Change
- BiotechnologyIndustry
GENMAB SP ADR (GMAB)
$25.94+$0.33 (+1.29%)
Earnings Score
Valuation | GMAB | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | N/A | ||
Low Earnings Volatility | N/A |
Momentum Score
Valuation | GMAB | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 5.26% | ||
12-Month Momentum | 28.59% | ||
3-Month Risk Adjusted Momentum | 38.12% | ||
12-Month Risk Adjusted Momentum | 87.72% |
True Yield
Valuation | GMAB | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
No data found